News

New study identifies DNA signatures associated with risk for cardiovascular disease, a discovery that could lead to opportunities for clinical intervention years before symptoms manifest. Based on analyses of data from five large heart cohort studies of diverse populations, the findings are published in the journal JAMA Cardiology.

A new study reveals that an RNA-modifying protein known as METTL1 in tumor cells could be targeted to treat some aggressive cancers including brain, blood, skin, and kidney.

In the last few weeks, there have been large changes in the way COVID-19 has been spreading in the UK, particularly in younger age groups. The adult vaccine programme has progressed very successfully and more safety data has become available, so it was important to review the advice for the vaccination of children and young people.

More than 85 million doses of a coronavirus (COVID-19) vaccine have been administered across the UK. Over 88% of adults have had the first dose and over 72% of adults have had both doses.

A chronic gut disorder that occurs in regions with poor sanitation disrupts intestinal immune responses and impairs oral vaccine effectiveness in a mouse model of the disease, according to new research.

Researchers have found that mebendazole, an anti-parasitic drug, prevents the initiation, progression and metastasis of pancreatic cancer in genetically engineered mice.

Researchers are investigating whether a naturally occurring protein made in immune cells, called TRAIL, is effective in killing colon cancer cells.

Researchers have built a prototype artificial lower stomach to gain a deeper understanding of how physical forces influence food digestion based on fluid dynamics. This could aid research in many areas including obesity and drug absorption.

Researchers have created a new open-access database containing information on many drug candidates and how they are metabolized by the body, which could help speed up the repurposing of existing drugs.

AstraZeneca has announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released to over 170 countries.